Frontier Pharma: Diabetic Complications - Innovative and Diverse Neuropathies, Nephropathy and Retinopathies Pipelines Demonstrate Shift Towards Disease Modifying Therapies

Published: June 2016
No. of Pages: 73
    ReportsandReports

Diabetes is a common long-term condition that can lead to a range of disparate and serious complications. It is a lifelong, multi-systemic condition that affects a number of integral organs. Diabetes has a rapidly increasing prevalence – it currently affects 10% of adults globally, and is estimated to become the seventh-leading cause of death by 2030.

The lack of absolute treatment for the condition and the difficulty in maintaining constant glycemic control, even following adequate treatment, can result in a range of complications. The three main indication groups are diabetic nephropathy, which is a progressive condition caused by damage to the capillaries and kidneys glomeruli as a result of diabetes; diabetic retinopathy, which is defined as damage to the retina as a result of high blood sugar; and a range of diabetic neuropathies, a group of conditions in which nerve damage is caused as a result of diabetes mellitus.

The need for improved therapeutics within diabetic complications is especially prominent in comparison with other multi-systemic conditions, as the market is currently predominantly composed of therapies that symptomatically treat the condition, or at best slow disease progression. However, as the understanding of disease pathophysiology in both diabetes and its complications increases, new targets are being identified and converted into improved therapeutic options that are better aligned with the underlying disease pathophysiology than their predecessors.

The diabetic complications pipeline consists of 429 products that contain an array of targets not currently in use within the market. The increase in molecular target diversity signifies the high potential for changes and improvements in the diabetic complications market. One innovative therapy is CBX-129801, a promising synthetic peptide that is currently in development for diabetic neuropathy. Innovation can also be seen within diabetic retinopathy, with therapies such as BCN070660, a topical ophthalmologic formulation currently in development.

Scope

  • What effect do current market therapies have on disease progression?
  • Which drug classes dominate the current market?
  • What additional benefits have newly approved therapies brought to the market?
  • Can the increasing number of peptides in the pipeline prove useful in diabetic neuropathy?
  • Can neuroprotective therapies prove an important addition in diabetic retinopathies?
  • Can the diverse range of molecule types and molecular targets within the pipeline help reverse disease progression?
  • To what degree is the pipeline penetrated by first-in-class innovation?
  • What is the clinical potential of first-in-class products, based on their alignment to disease-causing pathways?
  • Which are the most promising first-in-class targets in early-stage development?
  • Which of the first-in-class products in development are not currently involved in a licensing or co-development deal, and therefore represent investment opportunities?

Reasons to buy

  • Understand the current clinical and commercial landscape. It includes a comprehensive study of disease pathogenesis, diagnosis, prognosis and the treatment options available.
  • Visualize the composition of the market for each diabetic complication individually, in terms of dominant molecule types and targets, highlighting what the current unmet needs are and how they can be addressed. This knowledge allows a competitive understanding of gaps in the current market.
  • Analyze the pipeline for each diabetic complication individually and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking more innovative approaches to treating diabetic complications.
  • Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
  • Identify commercial opportunities in the diabetic complications deals landscape by analyzing trends in licensing and co-development deals and producing a curated list of diabetic complications therapies that are not yet involved in deals, and may be potential investment opportunities.

Published By: GBI Research
Product Code: GBI Research1561


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • China Self-fixating Hernia Mesh Market Research Report 2017

    Notes: Sales, means the sales volume of Self-fixating Hernia Mesh Revenue, means the sales value of Self-fixating Hernia Mesh This report studies Self-fixating Hernia Mesh in China market, focuses on the top players in China market, with capacit...

  • China Salicylamide Market Research Report 2017

    Notes: Sales, means the sales volume of Salicylamide Revenue, means the sales value of Salicylamide This report studies Salicylamide in China market, focuses on the top players in China market, with capacity, production, price, revenue and marke...

  • China Oral Hygiene Market Research Report 2017

    Notes: Sales, means the sales volume of Oral Hygiene Revenue, means the sales value of Oral Hygiene This report studies Oral Hygiene in China market, focuses on the top players in China market, with capacity, production, price, revenue and marke...

  • China Ophthalmic Drug Market Research Report 2017

    Notes: Sales, means the sales volume of Ophthalmic Drug Revenue, means the sales value of Ophthalmic Drug This report studies Ophthalmic Drug in China market, focuses on the top players in China market, with capacity, production, price, revenue ...

  • China Oligonucleotide Synthesis Market Research Report 2017

    Notes: Sales, means the sales volume of Oligonucleotide Synthesis Revenue, means the sales value of Oligonucleotide Synthesis This report studies Oligonucleotide Synthesis in China market, focuses on the top players in China market, with capacit...

  • China Oil Softgel Capsules Market Research Report 2017

    Notes: Sales, means the sales volume of Oil Softgel Capsules Revenue, means the sales value of Oil Softgel Capsules This report studies Oil Softgel Capsules in China market, focuses on the top players in China market, with capacity, production, ...

  • China Non-Specific Cancer Immunotherapy Drug Market Research Report 2017

    Notes: Sales, means the sales volume of Non-Specific Cancer Immunotherapy Drug Revenue, means the sales value of Non-Specific Cancer Immunotherapy Drug This report studies Non-Specific Cancer Immunotherapy Drug in China market, focuses on the t...

  • China Non-animal Softgel Capsules Market Research Report 2017

    Notes: Sales, means the sales volume of Non-animal Softgel Capsules Revenue, means the sales value of Non-animal Softgel Capsules This report studies Non-animal Softgel Capsules in China market, focuses on the top players in China market, with c...

  • China Neuromyelitis Optica Drug Market Research Report 2017

    Notes: Sales, means the sales volume of Neuromyelitis Optica Drug Revenue, means the sales value of Neuromyelitis Optica Drug This report studies Neuromyelitis Optica Drug in China market, focuses on the top players in China market, with capacit...

  • Europe Vegetarian Softgel Capsules Market Report 2017

    Notes: Sales, means the sales volume of Vegetarian Softgel Capsules Revenue, means the sales value of Vegetarian Softgel Capsules This report studies sales (consumption) of Vegetarian Softgel Capsules in Europe market, especially in Germany, Fra...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: